The Chemours Company (FRA:2CU)
Germany · Delayed Price · Currency is EUR 12.54
-0.04 (-0.36%)
At close: Jan 30, 2026
The Chemours Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 5,837 | 5,782 | 6,078 | 6,831 | 6,345 | 4,969 | |
Revenue Growth (YoY) | 0.03% | -4.87% | -11.02% | 7.66% | 27.69% | -10.08% |
Cost of Revenue | 4,813 | 4,631 | 4,772 | 5,215 | 4,964 | 3,902 |
Gross Profit | 1,024 | 1,151 | 1,306 | 1,616 | 1,381 | 1,067 |
Selling, General & Admin | 577 | 602 | 526 | 705 | 583 | 526 |
Research & Development | 107 | 109 | 108 | 118 | 107 | 93 |
Other Operating Expenses | - | - | - | - | - | 1 |
Operating Expenses | 684 | 711 | 634 | 823 | 690 | 620 |
Operating Income | 340 | 440 | 672 | 793 | 691 | 447 |
Interest Expense | -269 | -264 | -208 | -163 | -185 | -210 |
Earnings From Equity Investments | 36 | 43 | 45 | 55 | 43 | 23 |
Currency Exchange Gain (Loss) | -10 | -9 | -38 | -15 | 3 | -26 |
Other Non Operating Income (Expenses) | 20 | 14 | 23 | 57 | 36 | 38 |
EBT Excluding Unusual Items | 117 | 224 | 494 | 727 | 588 | 272 |
Merger & Restructuring Charges | -67 | -60 | -153 | -16 | -6 | -32 |
Impairment of Goodwill | - | -56 | - | - | - | - |
Gain (Loss) on Sale of Assets | 5 | - | 106 | 23 | 115 | 8 |
Asset Writedown | - | - | - | - | - | -10 |
Legal Settlements | -263 | - | -764 | - | - | -37 |
Other Unusual Items | -1 | -1 | -1 | 7 | -21 | -22 |
Pretax Income | -189 | 127 | -318 | 741 | 676 | 179 |
Income Tax Expense | 130 | 41 | -81 | 163 | 68 | -40 |
Earnings From Continuing Operations | -319 | 86 | -237 | 578 | 608 | 219 |
Minority Interest in Earnings | -1 | - | -1 | - | - | - |
Net Income | -320 | 86 | -238 | 578 | 608 | 219 |
Net Income to Common | -320 | 86 | -238 | 578 | 608 | 219 |
Net Income Growth | - | - | - | -4.93% | 177.63% | - |
Shares Outstanding (Basic) | 150 | 149 | 149 | 155 | 165 | 165 |
Shares Outstanding (Diluted) | 150 | 150 | 149 | 158 | 169 | 166 |
Shares Change (YoY) | 0.18% | 0.85% | -5.93% | -6.16% | 1.41% | 0.93% |
EPS (Basic) | -2.13 | 0.58 | -1.60 | 3.72 | 3.69 | 1.33 |
EPS (Diluted) | -2.13 | 0.57 | -1.60 | 3.65 | 3.60 | 1.32 |
EPS Growth | - | - | - | 1.39% | 172.73% | - |
Free Cash Flow | -12 | -993 | 186 | 448 | 537 | 540 |
Free Cash Flow Per Share | -0.08 | -6.61 | 1.25 | 2.83 | 3.18 | 3.25 |
Dividend Per Share | 0.675 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 |
Dividend Growth | -32.50% | - | - | - | - | - |
Gross Margin | 17.54% | 19.91% | 21.49% | 23.66% | 21.77% | 21.47% |
Operating Margin | 5.83% | 7.61% | 11.06% | 11.61% | 10.89% | 9.00% |
Profit Margin | -5.48% | 1.49% | -3.92% | 8.46% | 9.58% | 4.41% |
Free Cash Flow Margin | -0.21% | -17.17% | 3.06% | 6.56% | 8.46% | 10.87% |
EBITDA | 659 | 741 | 979 | 1,084 | 1,008 | 767 |
EBITDA Margin | 11.29% | 12.82% | 16.11% | 15.87% | 15.89% | 15.44% |
D&A For EBITDA | 319 | 301 | 307 | 291 | 317 | 320 |
EBIT | 340 | 440 | 672 | 793 | 691 | 447 |
EBIT Margin | 5.83% | 7.61% | 11.06% | 11.61% | 10.89% | 9.00% |
Effective Tax Rate | - | 32.28% | - | 22.00% | 10.06% | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.